Hydroquinone ansamycin formulations

Details for Australian Patent Application No. 2008240179 (hide)

Owner Infinity Discovery, Inc.

Inventors Porter, James R.; Wright, James L.

Agent Shelston IP

Pub. Number AU-A-2008240179

PCT Pub. Number WO2008/128063

Priority 60/911,330 12.04.07 US

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/7016 (2006.01) - Disaccharides, e.g. lactose, lactulose

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/128063 Priority application(s): WO2008/128063

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240181-Tuberculosis vaccine and method of using same

2008240177-Functionally graded metal matrix composite sheet